Published in:
Volume 9 / Year 2020 / Issue 3

Pelmeg®, a biosimilar pegfilgrastim developed in the context of evolving regulatory guidelines

Author(s): , , , ,
Page: 125-31

Author byline as per print journal: Karsten Roth, PhD; Hendrik Wessels, PhD; Josef Höfler, PhD; Ulrike Scholz, PhD; Dirk Lehnick, PhD Abstract: Pelmeg® is a biosimilar pegfilgrastim, which obtained European… Read More »

Go Back Print